<- Go Home
Nuvectra Corporation
On June 2, 2020, Nuvectra Corporation went out of business as per its Chapter 7 liquidation filing under bankruptcy. Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson’s disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.
Market Cap
$268.3K
Volume
255.0K
Cash and Equivalents
$69.8M
EBITDA
-$44.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$26.5M
Profit Margin
52.10%
52 Week High
$4.30
52 Week Low
$0.01
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
-0.01
Price / Tangible Book Value
0.01
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$45.4M
Return on Equity
83.43%
Return on Assets
-24.11
Cash and Short Term Investments
$69.8M
Debt
$46.7M
Equity
$69.5M
Revenue
$50.9M
Unlevered FCF
-$28.7M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium